6SZG
Acinetobacter baumannii undecaprenyl pyrophosphate synthase (AB-UppS) in complex with GR839 and GSK513
6SZG の概要
| エントリーDOI | 10.2210/pdb6szg/pdb |
| 分子名称 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific), 4,5,6,7-tetrahydro-2~{H}-indazole-3-carboxylic acid, (4-chlorophenyl)-[(3~{S})-3-oxidanylpiperidin-1-yl]methanone, ... (5 entities in total) |
| 機能のキーワード | inhibitor complex, transferase |
| 由来する生物種 | Acinetobacter baumannii |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 62255.70 |
| 構造登録者 | |
| 主引用文献 | Thorpe, J.H.,Wall, I.D.,Sinnamon, R.H.,Taylor, A.N.,Stavenger, R.A. Cocktailed fragment screening by X-ray crystallography of the antibacterial target undecaprenyl pyrophosphate synthase from Acinetobacter baumannii. Acta Crystallogr.,Sect.F, 76:40-46, 2020 Cited by PubMed Abstract: Direct soaking of protein crystals with small-molecule fragments grouped into complementary clusters is a useful technique when assessing the potential of a new crystal system to support structure-guided drug discovery. It provides a robustness check prior to any extensive crystal screening, a double check for assay binding cutoffs and structural data for binding pockets that may or may not be picked out in assay measurements. The structural output from this technique for three novel fragment molecules identified to bind to the antibacterial target Acinetobacter baumannii undecaprenyl pyrophosphate synthase are reported, and the different physicochemical requirements of a successful antibiotic are compared with traditional medicines. PubMed: 31929185DOI: 10.1107/S2053230X19017199 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.84 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






